Special Issue "Research on Immune Response and Vaccines"
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: 31 October 2022 | Viewed by 328
2. Department of Rheumatology, King's College School of Medicine, King's College London, Weston Education Centre, 10 Cutcombe Road, Denmark Hill, London SE5 9RJ, UK
Interests: Rheumatoid Arthritis; inflammatory arthritis and biologic therapy
The importance of vaccination has gained much attention, due to the advent of COVID-19 pandemic. However, despite decades of research, many diseases, including bacterial, fungal, parasitic and viral, are not having efficacious vaccines. The ultimate goal of vaccination is to generate a safe and effective long-term immune response against targeted disease.
Most vaccines work by mimicking infections. Vaccines activate the immune system and generate memory T and B lymphocytes that "remember" the disease-causing agents. Upon encountering these pathogens later, the immune system will mount a rapid and robust immune response to antigens it has previously experienced, thereby preventing disease or reducing its severity. The initial response to a vaccine is similar to the primary response upon first exposure to a pathogen, that is, slow and limited.
In this Special Issue, we will collect articles research related to vaccine efficacy and effectiveness, vaccine failure, herd immunity, herd effect, epidemiological transfer. Specifically, vaccine-related immune responses. We invite research employing quantitative and qualitative methods as well as contributions featuring under-researched populations.
Dr. James Galloway
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.